+1-646-568-9980, +44-203-287-6050
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
global dry eyes disease market

Global Dry Eyes Disease Market, [by Disease type (Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome); by Product Type (Oral Corticosteroids, Artificial Tears, Cyclosporine, Omega Supplements, Punctual Bags (Removable Bags, Dissolvable Bags), Others); by End Use (Retail Pharmacies, Hospital Pharmacy, Others)]; and Geography - Trend, Analysis and Forecast till 2025

Published: Jun 2018
Pages: 0
Format: PDF
Report ID: PM1329
License and Pricing
Buy Now Inquire Before Buying

Report Summary

The Global Dry Eyes Disease Market is estimated to gain traction owing to the rising preference for the sedentary lifestyle, and continuous efforts of the manufacturers that are focusing on developing new products in the competitive market.

Dry eye disease is caused due to lack of sufficient lubrication, moisture or tear on the surface of eyes making them healthy and comfortable. Whenever, a person blinks, the film of tears spreads over the eyes keeping the surface smooth which is important for good vision. The tear film is made up of 3 layers namely; Oily layer, Water layer, and mucus layer. Dry eye disease is recognised by constant eye irritation, significant inflammation, and sometimes scarring of the front surface of the eye.

Dry eye is recognised by increased tear evaporation, due to excessive medication such as decongestant, and birth control pills. Moreover, increasing age is a risk factor that can cause dry eye disease, seasonal dry eyes, and sometimes laser eye treatment also cause short term dry eyes. Drugs commonly prescribed by the doctors for treating dry eye are Cyclosporine corticosteroids eye drops.

Rising number of technologically advanced novel treatments that are used for effective treatment of dry eyes disease and significant geriatric population globally boosts the dry eye disease market.

The dry eyes disease market is basically driven by the rising prevalence of geriatric population, and increased number of clinical trials that focus on the development of new and effective treatment of dry eye disease in the market. Similarly, the rising technological advancements and continuous product development would also influence the market growth. Moreover, increased government focus on improving the efficiency and safety of drugs used in treating dry eyes will drive the market significantly in the coming years.

However, some regulatory framework issues and strict regulations for approval of drugs, and lack of trained ophthalmologist are the factors hampering the dry eyes disease market.

Global Dry Eyes Disease Market Taxonomy

The dry eyes disease market is segmented on the basis of disease type, product type, end use and geography.

On the basis of disease type, the global dry eyes disease market size is segmented as:

  • Evaporative Dry Eye Syndrome
  • Aqueous Dry Eye Syndrome

On the basis of product type, the global dry eyes disease market share is segmented as:

  • Oral Corticosteroids
  • Artificial Tears
  • Cyclosporine
  • Omega Supplements
  • Punctual Bags
  • Removable Bags
  • Dissolvable Bags
  • Others

On the basis of end use type, the global dry eyes disease market size is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Geographically, the dry eyes disease market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Increased healthcare expenditure and research & development expenditure to lead the global dry eyes disease market size in North America.

On the basis of geography, North America is expected to dominate the dry eye disease market over forecast period. Increasing prevalence of geriatric population and increased prevalence of dry eye syndrome in this region would also influence the dry eye disease market in North America. Europe holds the second largest share in the dry eyes disease market owning to the increasing pool of older population in the coming years.

However, Asia Pacific dry eyes disease market to grow at a faster rate during the forecast period. Higher population, and availability of treatment drugs at an economic cost are the major factor anticipated to govern the dry eyes disease market during upcoming years. Nonetheless, high cost of treatment and scarcity of skilled ophthalmologist for treat dry eye disease in the developing countries of Asia-Pacific region can hamper the dry eyes market share growth in this region.

Key players in the global dry eyes disease market are:

  • Novartis AG.
  • Allergan Inc.
  • Valent Pharmaceuticals
  • Acadia Pharmaceuticals
  • Johnson & Johnson Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Novaliq GmbH
  • Auven Therapeutics
  • I-Men Pharmaceuticals
  • Allostera Pharma
  • AFT Pharmaceuticals
  • Otsuka Pharmaceuticals Co. Ltd.
Key Take-Away